Norwalk, CT.—October 31, 2005— Reed Elsevier announced today that Dr Janet Woodcock, Deputy Commissioner for Operations and Chief Operating Officer, US Food and Drug Administration, Dr Christopher P. Austin, Director, NIH Chemical Genomics Centre, National Institutes of Health, and Dr John L. LaMattina, Senior Vice President, Pfizer Inc and President, Pfizer Global Research and Development will take part in an Opening Keynote Session at PharmaDiscovery, May 10-12, Bethesda North Marriott Hotel and Conference Center in North Bethesda, Maryland. Each will give their perspective on the impact of innovation in drug discovery and development and will debate how the FDA, NIH and industry can work together more effectively in the future to promote innovation.

Dr Steve Carney, Managing Editor of Elsevier’s Drug Discovery Today journal said “This is a unique opportunity to bring together such eminent scientific leaders, pivotal in driving innovation forward within their own organisations, to debate the future impact of innovation. At this crucial time, with attention focused on R&D productivity, attrition and pipeline strengths, it is now more important than ever that R&D Scientists fully understand the potential and shortfalls of each tool and technology”.

** The Conference **
PharmaDiscovery is produced by Elsevier and Reed Life Sciences, and is sponsored by Reed Business Information. The conference will align its aims with the FDA’s recent White Paper “Innovation or Stagnation – Challenge and Opportunity on the Critical Path to New Medical Products” and will provide a forum for R&D Leaders to assess the impact of innovation within drug discovery and development. PharmaDiscovery is designed to stir debate and discussion in the scientific community and turn discussion into actionable recommendations and tactics that can be applied immediately to drive positive changes in pharma R&D. Conference sessions include: Novel Approaches to Target Identification and Validation, Systems and Pathways Approaches to Drug Discovery, Innovation in Information and Applied Knowledge, Cell Based and Whole Animal Imaging, Virtual Screening and ADME, Novel Screening Technologies, New Developments in the Hit to Lead Process, In Vivo Models of Disease, Biomarkers, Enabling Technologies for Candidate Selection and Clinical Trials, and Case Studies in CNS Diseases, Cardiovascular Disease and Oncology.

** The Supporting Technology and Sponsorship Area **
A supporting technology and sponsorship area will feature roundtable discussions, technical vendor presentations and products and services aiding in the productivity and success of drug discovery. Current sponsors include: Fujitsu, Perkin Elmer, NIH, Metabalon, Schrodinger, Kalexsyn and the Chemical Computing Group. The sponsorship area will have 20-25 sponsors during the event dates, May 10-12, 2006.

** Organizers and Sponsors **

*Reed Life Sciences Group*
Reed Life Sciences is the targeted life sciences events group designed to focus on scientific conferences and events within the life sciences spectrum. The events will cover the entire continuum from discovery, clinical development and commercialization. Reed Life Science events include PharmaDiscovery, INTERPHEX USA, INTERPHEX Puerto Rico, Medical Device Puerto Rico, INTERPHEX Mexico and other global life science events.

*Elsevier*
Elsevier is the respected global leader in scientific, technical and medical products including the highly regarded journals Drug Discovery Today, Cell, Tetrahedron, the Lancet, and the renowned scientific information platform, ScienceDirect.

*Reed Business Information*
Reed Business Information has a portfolio of more than 100 publications (including Drug Discovery & Development Magazine,
Bioscience Technology, Scientific Computing & Instrumentation Magazine, Genomics & Proteomics, Laboratory Equipment and R&D Magazine),newsletters, directories and reference books, electronic products, online services, conferences and awards. Its titles cover 18 markets in the UK, US and Asia.

For more information about PharmaDiscovery, visit: www.pharmadiscoveryevent.com